Previously, (Hähnke et al., J Comput Chem 2009, 30, 761) we presented the Pharmacophore Alignment Search Tool (PhAST), a ligand-based virtual screening technique representing molecules as strings coding pharmacophoric features and comparing them by global pairwise sequence alignment. To guarantee unambiguity during the reduction of two-dimensional molecular graphs to one-dimensional strings, PhAST employs a graph canonization step. Here, we present the results of the comparison of 11 different algorithms for graph canonization with respect to their impact on virtual screening. Retrospective screenings of a drug-like data set were evaluated using the BEDROC metric, which yielded averaged values between 0.4 and 0.14 for the best-performing and worst-performing canonization technique. We compared five scoring schemes for the alignments and found preferred combinations of canonization algorithms and scoring functions. Finally, we introduce a performance index that helps prioritize canonization approaches without the need for extensive retrospective evaluation.

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcc.21574DOI Listing

Publication Analysis

Top Keywords

pharmacophore alignment
8
alignment search
8
search tool
8
virtual screening
8
graph canonization
8
canonization
5
tool influence
4
influence canonical
4
canonical atom
4
atom labeling
4

Similar Publications

ROSHAMBO: Open-Source Molecular Alignment and 3D Similarity Scoring.

J Chem Inf Model

November 2024

Medicinal Chemistry, Biogen, Cambridge, Massachusetts 02142, United States.

Efficient virtual screening techniques are critical in drug discovery for identifying potential drug candidates. We present an open-source package for molecular alignment and 3D similarity calculations optimized for large-scale virtual screening of small molecules. This work parallels widely used proprietary tools and offers an approach complementary to structure-based virtual screening.

View Article and Find Full Text PDF

Background And Purpose: Drug repurposing (DR) offers a compelling alternative to traditional drug discovery's lengthy, resource-intensive process. DR is the process of identifying alternative clinical applications for pre-approved drugs as a low-risk and low-cost strategy. Computational approaches are crucial during the early hypothesis-generating stage of DR.

View Article and Find Full Text PDF
Article Synopsis
  • The 21st century has seen increasing variations of pathogens, leading to significant global health issues, particularly malaria and oxidative damage, which necessitate the search for effective treatments.* -
  • Research is focused on the antioxidant potential of transition metal (II) complexes with tridentate Schiff base ligands, as they might enhance both anti-malarial and antioxidant activities, offering a two-fold therapeutic benefit.* -
  • Investigations into various metal complexes showed that some, particularly the Hg(II) complex, exhibit strong anti-malarial properties similar to quinine, while Cu(II) and Zn(II) complexes demonstrate significant antioxidant capabilities, supported by molecular docking studies to assess their pharmacological interactions.*
View Article and Find Full Text PDF

The article explores the polypharmacological profiling of 4-((5-(decylthio)-4-methyl-4H-1,2,4-triazole-3-yl)methyl)morpholine as a potential antimicrobial agent. The study utilized 15148 electronic pharmacophore models of organisms, ranked by the Tversky index. Detailed analysis revealed classical bonding patterns with selected enzymes, identifying key amino acid residues involved in complex formation.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers are focusing on DprE1, a key enzyme in tuberculosis that is difficult to target due to its size and location, as a potential target for new anti-tuberculosis drugs.
  • Benzothiazinone has shown promise as a pharmacophore for inhibiting DprE1, with several clinical trial drugs achieving promising results.
  • A study developed a robust 3D QSAR model to identify effective Benzothiazinone derivatives, alongside docking studies that supported the design of new compounds aimed at combating tuberculosis.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!